News & Updates

Show Multimedia Only

SGLT2 inhibitors easy on the kidneys of Asians with T2D

22 Mar 2025 by

Among Asians with type 2 diabetes (T2D), users of sodium-glucose cotransporter-2 (SGLT2) inhibitors may have better kidney outcomes compared with those who use other glucose-lowering drugs.

SGLT2 inhibitors easy on the kidneys of Asians with T2D

22 Mar 2025

Vegetable oil use may prevent body fat accumulation in young adulthood

22 Mar 2025

A recent study has shown the inverse associations of plasma phospholipid proportions of linoleic acid (LA) and α-linolenic acid (ALA), biomarkers of vegetable oil intake, during childhood and adolescence with measures of obesity and cardiometabolic health in young adulthood. A potential sex difference has also been observed.

Vegetable oil use may prevent body fat accumulation in young adulthood

22 Mar 2025

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

21 Mar 2025

Increased consumption of lignans, specifically secoisolariciresinol (SECO), results in a significant reduction in overall cardiovascular disease (CVD) and cancer mortality among individuals with type 2 diabetes (T2D), a study has shown.

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

21 Mar 2025

GLP-1 RA use before endoscopy tied to low retained gastric contents

19 Mar 2025

Patients taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), particularly those with type 2 diabetes (T2D), have very low rates of retained gastric contents during endoscopy, as shown in a study.

GLP-1 RA use before endoscopy tied to low retained gastric contents

19 Mar 2025

Light movement in lieu of sedentary time improves cardiometabolic outcomes

19 Mar 2025 by

Data from the CARDIA study demonstrate that replacing sedentary time with light-intensity physical activity (LPA) is associated with improved cardiometabolic outcomes.

Light movement in lieu of sedentary time improves cardiometabolic outcomes

19 Mar 2025

GLP-1 RAs lower POAG, ocular hypertension risks in T2D patients

17 Mar 2025

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RA), compared with metformin, results in a significant decrease in the incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the need for first-line glaucoma treatments in patients with type 2 diabetes (T2D), reports a study.

GLP-1 RAs lower POAG, ocular hypertension risks in T2D patients

17 Mar 2025

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

Remnant cholesterol linked to low testosterone in men

13 Mar 2025

A close association exists between remnant cholesterol (RC) and the risk of low testosterone levels in adult men, suggests a nationwide study.

Remnant cholesterol linked to low testosterone in men

13 Mar 2025

Japanese adults with obesity lose weight with once-weekly tirzepatide

10 Mar 2025

Taking tirzepatide once a week appears to result in clinically meaningful reductions in body weight for Japanese adults with obesity, according to the results of the phase III multicentre SURMOUNT-J trial

Japanese adults with obesity lose weight with once-weekly tirzepatide

10 Mar 2025

Original New Drug Application Approvals by US FDA (1-15 February 2025)

10 Mar 2025

New drug applications approved by US FDA as of 1-15 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 February 2025)

10 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

SGLT2 inhibitors easy on the kidneys of Asians with T2D

SGLT2 inhibitors easy on the kidneys of Asians with T2D

Vegetable oil use may prevent body fat accumulation in young adulthood

Vegetable oil use may prevent body fat accumulation in young adulthood

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

GLP-1 RA use before endoscopy tied to low retained gastric contents

GLP-1 RA use before endoscopy tied to low retained gastric contents

Light movement in lieu of sedentary time improves cardiometabolic outcomes

Light movement in lieu of sedentary time improves cardiometabolic outcomes

GLP-1 RAs lower POAG, ocular hypertension risks in T2D patients

GLP-1 RAs lower POAG, ocular hypertension risks in T2D patients

Original New Drug Application Approvals by US FDA (16-28 February 2025)

Original New Drug Application Approvals by US FDA (16-28 February 2025)

Remnant cholesterol linked to low testosterone in men

Remnant cholesterol linked to low testosterone in men

Japanese adults with obesity lose weight with once-weekly tirzepatide

Japanese adults with obesity lose weight with once-weekly tirzepatide

Original New Drug Application Approvals by US FDA (1-15 February 2025)

Original New Drug Application Approvals by US FDA (1-15 February 2025)